-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

Circulating H3K27 nucleosomes to monitor lung cancer patients during treatment
- Share
- Tweet
- Share on Facebook
- Share


Paper titled: Circulating H3K27 Nucleosomes to monitor Lung Cancer Patients During Treatment, a universal biomarker quantifiying the minimal residual disease (MRD) in plasma samples.
Grolleau et al 2023
Presented at AACCR 2023
Related Articles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields